Strategy for rapid identification and antibiotic susceptibility testing of gram-negative bacteria directly recovered from positive blood cultures using the Bruker MALDI biotyper and the BD phoenix system

Journal of Clinical Microbiology

Volumn 50, Issue 7, 2012, Pages 2452-2454

  Wimmer, Jana L ^a   Long, S Wesley ^a,b   Cernoch, Patricia ^a   Land, Geoffrey A ^a   Davis, James R ^a   Musser, James M ^a,b   Olsen, Randall J ^a,b  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; AZTREONAM; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; RNA 16S; SULTAMICILLIN; TETRACYCLINE; TOBRAMYCIN;

ACCURACY; ACHROMOBACTER; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM DETECTION; BLOOD CULTURE; CITROBACTER FREUNDII; CULTURE MEDIUM; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; GENE SEQUENCE; GRAM NEGATIVE BACTERIUM; HUMAN; KLEBSIELLA PNEUMONIAE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; MORGANELLA MORGANII; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEUS MIRABILIS; PROVIDENCIA STUARTII; RELIABILITY; SERRATIA MARCESCENS; STENOTROPHOMONAS MALTOPHILIA; VALIDITY;

ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL TYPING TECHNIQUES; BLOOD; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TIME FACTORS;

EID: 84862731332     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00409-12     Document Type: Article

References (16)

1. Barenfanger J, Drake C, Kacich G. 1999. Clinical and financial benefits of rapid bacterial identification and antimicrobial susceptibility testing. J. Clin. Microbiol. 37:1415-1418.
2. Baron EJ, et al. 2005. Cumitech 1C: blood cultures IV. ASM Press, Washington, DC.
3. Bruins MJ, Bloembergen P, Ruijs GJ, Wolfhagen MJ. 2004. Identification and susceptibility testing of Enterobacteriaceae and Pseudomonas aeruginosa by direct inoculation from positive BACTEC blood culture bottles into Vitek 2. J. Clin. Microbiol. 42:7-11.
4. Buchan BW, Riebe KM, Ledeboer NA. 2012. Comparison of the MALDI Biotyper system using Sepsityper specimen processing to routine microbiological methods for identification of bacteria from positive blood culture bottles. J. Clin. Microbiol. 50:346-352.
5. Chen JR, Lee SY, Yang BH, Lu JJ. 2008. Rapid identification and susceptibility testing using the VITEK 2 system using culture fluids from positive BacT/ALERT blood cultures. J. Microbiol. Immunol. Infect. 41:259-264.
6. CLSI. 2008. Development of in vitro susceptibility testing criteria and quality control parameters, 3rd ed. Clinical and Laboratory Standards Institute, Wayne, PA.
7. Doern GV, Vautour R, Gaudet M, Levy B. 1994. Clinical impact of rapid in vitro susceptibility testing and bacterial identification. J. Clin. Microbiol. 32:1757-1762.
8. Funke G, Funke-Kissling P. 2004. Use of the BD PHOENIX Automated Microbiology System for direct identification and susceptibility testing of Gram-negative rods from positive blood cultures in a three-phase trial. J. Clin. Microbiol. 42:1466-1470.
9. Gherardi G, et al. 2012. Comparative evaluation of the Vitek-2 Compact and Phoenix systems for rapid identification and antibiotic susceptibility testing directly from blood cultures of Gram-negative and Gram-positive isolates. Diagn. Microbiol. Infect. Dis. 72:20-31.
10. Lupetti A, Barnini S, Castagna B, Nibbering PH, Campa M. 2010. Rapid identification and antimicrobial susceptibility testing of Gram-positive cocci in blood cultures by direct inoculation into the BD Phoenix system. Clin. Microbiol. Infect. 16:986-991.
11. Moussaoui W, et al. 2010. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry identifies 90% of bacteria directly from blood culture vials. Clin. Microbiol. Infect. 16:1631-1638.
12. Peleg AY, Hooper DC. 2010. Hospital-acquired infections due to Gram-negative bacteria. N. Engl. J. Med. 362:1804-1813.
13. Rittenhouse SF, Miller LA, Utrup LJ, Poupard JA. 1996. Evaluation of 500 Gram-negative isolates to determine the number of major susceptibility interpretation discrepancies between the Vitek and MicroScan Walkaway for 9 antimicrobial agents. Diagn. Microbiol. Infect. Dis. 26: 1-6.
14. Russell JA. 2006. Management of sepsis. N. Engl. J. Med. 355:1699-1713.
15. Stevenson LG, Drake SK, Murray PR. 2010. Rapid identification of bacteria in positive blood culture broths by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J. Clin. Microbiol. 48: 444-447.
16. Trenholme GM, et al. 1989. Clinical impact of rapid identification and susceptibility testing of bacterial blood culture isolates. J. Clin. Microbiol. 27:1342-1345.